Zobrazeno 1 - 9
of 9
pro vyhledávání: '"David S. Tofovic"'
Autor:
Anish S. Shah, Ana Ongtengco, Victor Qiao, Yining Chen, Annette Diaz, Michael Hill, Adarsh Bhan, David S. Tofovic, Dawood Darbar
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 10 (2024)
Background Genetic and familial contributions to early‐onset atrial fibrillation are described primarily in individuals of European ancestry. However, the role of racial and familial contributions in the pathogenesis of early‐onset atrial flutter
Externí odkaz:
https://doaj.org/article/72e22645f5b44b1a990a4c62ac779aa3
Autor:
Mahazarin Ginwalla, David S. Tofovic
Publikováno v:
Heart Failure Clinics. 14:601-616
Inotropes are medications that improve the contractility of the heart and are used in patients with low cardiac output or evidence of end-organ dysfunction. Since their initial discovery, inotropes have held promise in alleviating symptoms and potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd51a6c830e1e2f9e4290279458c995
https://doi.org/10.1016/j.hfc.2018.06.010
https://doi.org/10.1016/j.hfc.2018.06.010
Autor:
Muhammad S. Panhwar, Mahazarin Ginwalla, Sadeer G. Al-Kindi, Guilherme H. Oliveira, David S. Tofovic
Publikováno v:
Journal of cardiac failure. 25(9)
Outcomes of patients with amyloid cardiomyopathy (ACM) undergoing heart transplantation have been reported, but there are scant data concerning the waitlist mortality (WLM) of these patients.The aim of this study was to investigate whether patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed2b56ac14a48b98fd2b7912726c1a7
https://pubmed.ncbi.nlm.nih.gov/31291599
https://pubmed.ncbi.nlm.nih.gov/31291599
Autor:
Abdullah Almasoud, Guilherme H. Oliveira, Sanjay Rajagopalan, David S. Tofovic, Mahazarin Ginwalla, Robert Schilz, Jane A. Little, Sadeer G. Al-Kindi, Tara Alin
Publikováno v:
American journal of hematology. 93(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd18b2129bfdddcaa46b59492d27c84
https://pubmed.ncbi.nlm.nih.gov/28971490
https://pubmed.ncbi.nlm.nih.gov/28971490
Publikováno v:
Journal of Cardiac Failure. 23:S22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52977763728fad923c7987fd01250c9e
https://doi.org/10.1016/j.cardfail.2017.07.044
https://doi.org/10.1016/j.cardfail.2017.07.044
Autor:
Guilherme H. Oliveira, Robert Schilz, Jane A. Little, David S. Tofovic, Mahazarin Ginwalla, Sadeer G. Al-Kindi
Publikováno v:
Journal of Cardiac Failure. 23:S77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da6917c9e2f38e3a2622b27123f98ce8
https://doi.org/10.1016/j.cardfail.2017.07.219
https://doi.org/10.1016/j.cardfail.2017.07.219
Publikováno v:
Case Reports in Internal Medicine. 4:57
The combination of ipilimumab and nivolumab has shown great promise in improving survival in patients with advanced melanoma. However, these novel agents are not without side effects, with adverse events occurring in up to 55% of patients on combinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44a6480a09e03a3bbefe155e0f5a637e
https://doi.org/10.5430/crim.v4n3p57
https://doi.org/10.5430/crim.v4n3p57
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 37:689-691
1. Dipeptidyl peptidase (DPP) IV inhibitors enhance renovascular responses to angiotensin (Ang) II in spontaneously hypertensive rats (SHR), but not Wistar-Kyoto rats. Because DPPIV inhibitors are often used in metabolic syndrome, it is important to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca59fd0092b9e123fd44bf4364903abd
https://doi.org/10.1111/j.1440-1681.2010.05389.x
https://doi.org/10.1111/j.1440-1681.2010.05389.x
Publikováno v:
Clinical and experimental pharmacologyphysiology. 37(7)
1. Dipeptidyl peptidase (DPP) IV inhibitors enhance renovascular responses to angiotensin (Ang) II in spontaneously hypertensive rats (SHR), but not Wistar-Kyoto rats. Because DPPIV inhibitors are often used in metabolic syndrome, it is important to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::93725691b51e64d1ddac491aa46c9dd0
https://pubmed.ncbi.nlm.nih.gov/20374254
https://pubmed.ncbi.nlm.nih.gov/20374254